Market news

FDA warns Neogen Vet after fungal contamination in HYCOAT solution caused unprecedented horse deaths and severe manufacturing defects.

Neogen will report Q1 earnings Oct. 6, with EPS forecast at 5 cents and revenue at $208.18M; analysts recently raised ratings and targets.

Neogen has delivered a sharp share price swing in a short span, and the recent run has investors asking whether the current valuation is still grounded in its sales profile. With the stock now reflecting a very different market view than a few years ago, the key issue is how that view lines up with what the business actually generates in revenue. The stock has returned 153.2% over the past year, which puts real pressure on the question of whether today’s price can be explained by its sales...

Tipranks Press Release.

LANSING, Mich., September 15, 2026--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results.

Over the past six months, Neogen has been a great trade, beating the S&P 500 by 8.3%. Its stock price has climbed to $11.93, representing a healthy 21% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

NEOG advances product innovation and recovers Animal Safety operations, but high debt and intense competition remain key risks.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Recent commentary around Neogen (NEOG) has focused on two pressure points for investors. Annual sales have declined for two years and returns on capital have shrunk, while a higher net debt to EBITDA ratio raises balance sheet sensitivity. The recent share price reflects that mixed picture. Neogen’s stock is up 29.5% on a 90 day share price return and 68.71% year to date, while the 1 year total shareholder return of 106.47% contrasts with a 3 year total shareholder return that has fallen...

Neogen stock has more than doubled over the past year, yet the broader valuation checks lean expensive rather than cheap, which may give investors pause after such a strong run. The share price has returned 106.5% over the past year, which sets a high bar for any further gains to be justified by fundamentals. Future growth in Neogen's revenue and cash generation can support the current share price, but any disappointment in execution or profitability may weigh heavily given the recent...

NEOG shares gain 102.8% in a year as R&D investments, Food Safety growth and improving Animal Safety conditions fuel momentum despite key risks.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Neogen (NEOG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Medical Devices & Supplies - Diversified Stocks Q2 Results: Benchmarking Neogen (NASDAQ:NEOG)

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Neogen Corporation recently reported fiscal fourth-quarter and full-year 2026 results, posting Q4 revenue of US$225.3 million with a US$11.3 million net loss, and issued fiscal 2027 revenue guidance of US$880 million to US$885 million alongside plans for increased R&D and transformation spending. Despite full-year revenue easing to US$870.4 million and a US$7.9 million annual net loss, Neogen sharply reduced losses from the prior year while boosting core revenue growth and outlining plans to...

Detailed price information for Pfizer Inc (PFE-N) from The Globe and Mail including charting and trades.

Neogen (NASDAQ:NEOG) Reports Strong Q2 CY2026, Stock Soars

Neogen (NASDAQ:NEOG) reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined in

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Neogen Corp (NEOG) reports a 7% year-over-year revenue increase in Q4, driven by food safety and animal health demand, while navigating foreign exchange pressures and supply chain disruptions.

LANSING, Mich., July 30, 2026--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2026 and provided financial guidance for its fiscal year first quarter and full fiscal year 2027.

Neogen (NEOG) reported fiscal Q4 adjusted earnings Thursday of $0.09 per diluted share, up from $0.0

Neogen (NEOG) delivered earnings and revenue surprises of +80.00% and +6.29%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Life sciences company Neogen (NASDAQ:NEOG) will be reporting earnings this Thursday morning. Here’s what to expect.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Detailed price information for Neogen Corp (NEOG-Q) from The Globe and Mail including charting and trades.

Neogen Chemicals Ltd (BOM:542665) reports a 34% revenue surge and strategic initiatives to navigate geopolitical and market uncertainties.

Tipranks Press Release.

Tipranks Press Release.

Detailed price information for Cardinal Health (CAH-N) from The Globe and Mail including charting and trades.

LANSING, Mich., July 20, 2026--Neogen® Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 30, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company’s performance for the fourth-quarter of fiscal year 2026.